Applied Therapeutics Inc (APLT) — Strategic Asset Allocation Index

Latest as of September 2022: 10.1%

Applied Therapeutics Inc (APLT) has a Strategic Asset Allocation Index of 10.1% as of September 2022. Strategic assets (PP&E of $970.00K plus long-term investments of $-) total $970.00K, measured against net assets of $9.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Applied Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.

SAAI

10.1%
Strategic Assets / Net Assets

Strategic Assets

$970.00K
PP&E + LT Investments

PP&E

$970.00K
USD

Net Assets

$9.63 Million
USD

Applied Therapeutics Inc Strategic Asset Allocation Index (2018–2021)

This chart shows how Applied Therapeutics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2021. As of September 2022, the index stands at 10.1%, representing strategic assets of $970.00K against net assets of $9.63 Million USD. For live market cap and overall valuation, see APLT market cap.

Annual Strategic Asset Allocation Index for Applied Therapeutics Inc (2018–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for Applied Therapeutics Inc from 2018 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See APLT net asset value for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2021 2.1% $1.30 Million $1.30 Million $- $62.54 Million ▼ 0.0 pp
2020 2.1% $1.71 Million $1.71 Million $- $81.94 Million ▼ -4.8 pp
2019 6.9% $2.23 Million $2.04 Million $199.00K $32.61 Million ▲ +6.9 pp
2018 0.0% $0.00 $0.00 $0.00 $15.82 Million
pp = percentage points